Stock listing
Virax Biolabs Group Limited
Selected listing: VRAX · NASDAQ · USD · US
Virax Biolabs Group Limited (NASDAQ:VRAX), Finance. Latest release Jul 20, 2026: Alliance Entertainment and Virax Interviews Aired on the RedChip Small…
- Ticker
- NASDAQ:VRAX
- Asset type
- Stock
- Sector
- Finance
- Industry
- Financial Conglomerates
- Exchange
- NASDAQ
- Currency
- USD
About Virax Biolabs Group Limited
The company focuses on developing and commercializing innovative solutions in the healthcare sector. Virax aims to address various medical challenges through its research and product offerings.
Latest news from Virax Biolabs Group Limited
Alliance Entertainment and Virax Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
July 19, 2026
Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement
July 16, 2026
Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds
July 10, 2026
Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds
July 9, 2026
Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics
July 9, 2026
Research Virax Biolabs Group Limited
Virax Biolabs Group Limited company profile
View the public company page for Virax Biolabs Group Limited on 6ix.
Virax Biolabs Group Limited news
Read company news and market updates connected to Virax Biolabs Group Limited.
Virax Biolabs Group Limited investor events
Find investor webinars, events, and replay context for Virax Biolabs Group Limited.